Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,415 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia

NCT00866073

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Medizinische Hochschule Hannover Hanover, Lower Saxony, Germany
  • Klinikum der Technischen Universität Aachen Aachen, Germany
  • Universitätsklinikum Düsseldorf Düsseldorf, Germany
  • Katholisches Krankenhaus Hagen Hagen, Germany
View Trial Details
Completed

A Study of Enzastaurin in Patients With Leukemia

NCT00452257

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Duarte, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States
View Trial Details
Completed

Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result

NCT00146120

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Department of Hematology / Oncology, University Hospital of Innsbruck Innsbruck, Austria
  • III Medical Department, Hematology and Oncology Center, Hanuschhospital Wien Vienna, Austria
  • Department of General Internal Medicine, University Hospital of Bonn Bonn, Germany
  • Department of Internal Medicine Hematology, Heinrich-Heine University Düsseldorf, Germany
View all 22 locations
View Trial Details
Completed

Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia

NCT00390897

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukaemia, +11 more
Locations
  • Hospital Ntra. Sra. Sonsoles Ávila, Avila, Spain
  • Hospital Son Dureta Palma de Mallorca, Balearic Islands, Spain
  • Hospital Clínic Barcelona, Spain
  • Hospital del Mar Barcelona, Spain
View all 51 locations
View Trial Details

Related conditions